We also sequenced the pro-apoptotic BCL2 family member BAX that mediates the apoptotic signal, as BAX mutations are reported in CLL and AML patients treated with venetoclax [38,39]. This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.